Ziqi Chen – Trademark Portfolio

Entity Type: 01

Ziqi Chen holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 24 (Fabrics) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CUHAI, JXEOS, ISENHU, and NORCHZI. The owner is based in Hunan.

Yanwanghu Town, Hanshou County

Group 2, North of Wuzhushan Village

Hunan 415913 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JXEOS
JXEOS
Registered 2025
NORCHZI
NORCHZI
Registered 2021
ISENHU
ISENHU
Registered 2020
CUHAI
CUHAI
Registered 2020

Trademark Classifications

Ziqi Chen's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

24
Fabrics (2 filings)

Textiles and textile goods; bed covers; table covers

25
Clothing (1 filing)

Clothing, footwear, headgear

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Ziqi Chen have?

Ziqi Chen has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Ziqi Chen file in?

Ziqi Chen files trademarks across 3 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 25 (Clothing), Class 5 (Pharmaceuticals). Class 24 covers textiles and textile goods; bed covers; table covers.

What are Ziqi Chen's most well-known trademarks?

Ziqi Chen's registered trademark portfolio includes well-known marks such as CUHAI, JXEOS, ISENHU, and NORCHZI. These are among 4 currently registered trademarks in the portfolio.

What is Ziqi Chen's trademark registration success rate?

Ziqi Chen has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.